Live feed07:05:00·296dPRReleasevia QuantisnowZenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 MillionByQuantisnow·Wall Street's wire, on your screen.RPRX· Royalty Pharma plcZBIO· Zenas BioPharma Inc.Health Care
